Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
7.27
+0.40 (5.90%)
At close: Apr 17, 2025, 4:00 PM
7.26
0.00 (-0.07%)
After-hours: Apr 17, 2025, 7:36 PM EDT
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $748.43 million as of April 17, 2025. Its market cap has decreased by -68.82% in one year.
Market Cap
748.43M
Enterprise Value
96.90M
1-Year Change
-68.82%
Ranking
Category
Stock Price
$7.27
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has decreased from $757.50M to $748.43M, a decrease of -1.20%. That is a compound annual growth rate of -0.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 748.40M | -36.98% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.93B |
| UnitedHealth Group | 535.14B |
| Johnson & Johnson | 370.90B |
| AbbVie | 303.70B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 224.94B |
| AstraZeneca | 210.38B |
| Novartis AG | 210.23B |